KKR to acquire Integer for $5.7bn
- Integer is a CDMO of medical devices for cardiology and vascular care, neuromodulation and cardiac rhythm management.
- KKR will establish a broad-based employee ownership and engagement program at Integer when the deal closes.
- Integer is based in Plano, Texas.
KKR has announced an agreement to take medical device manufacturer Integer Holdings Corporation private in a $5.7 billion all-cash transaction. The agreement was unanimously approved by Integer’s board.
Headquartered in Plano, Texas, Integer is a global contract development and manufacturing organization of medical devices used in cardiology and vascular care, neuromodulation and cardiac rhythm management. Its brands include Greatbatch Medical and Lake Region Medical, and it has offices in North and South America, Europe and Asia-Pacific.
KKR plans to invest in Integer’s capacity, technology, innovation and talent and will establish a broad-based employee ownership and engagement program upon the deal closing.
“Integer is an exceptional platform with highly differentiated capabilities across a global manufacturing footprint, a track record for quality and reliability, and a talented team operating in attractive, durable end-markets,” said Max Lin, partner at KKR, in a statement. “We are excited by the opportunity to deploy capital and resources to further advance Integer’s next chapter of growth and innovation.”
KKR will complete the investment through its core private equity strategy and finance it through a combination of equity and committed debt financing.
The transaction is expected to close by the end of 2026.
